Clinical trials in East Brunswick, NJ

23 recruiting studies have a site in or near East Brunswick, NJ, New Jersey.

Top conditions here

All conditions

Showing 23 of 23 studies

RecruitingPhase 3NCT07525206

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

Sponsor: AbbVie

East Brunswick, NJ · +17 more sites

RecruitingPhase 2 / Phase 3NCT06712316

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

Sponsor: BioNTech SE

East Brunswick, NJ · Florham Park, NJ · Paramus, NJ · +50 more sites

RecruitingPhase 1NCT07424833

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

Sponsor: Ascentage Pharma Group Inc.

East Brunswick, NJ · +4 more sites

RecruitingPhase 3NCT07625644

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

Sponsor: SystImmune Inc.

East Brunswick, NJ · +6 more sites

RecruitingPhase 1NCT07462377

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

Sponsor: EpiBiologics

East Brunswick, NJ · +5 more sites

RecruitingPhase 1 / Phase 2NCT07529717

First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer

Sponsor: AstraZeneca

East Brunswick, NJ · Hackensack, NJ · +2 more sites

RecruitingPhase 2NCT07745361

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

Sponsor: Monte Rosa Therapeutics, Inc

East Brunswick, NJ · +13 more sites

RecruitingPhase 3NCT06790693

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Sponsor: Hoffmann-La Roche

East Brunswick, NJ · Florham Park, NJ · +60 more sites

RecruitingPhase 2 / Phase 3NCT07155187

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Sponsor: AbbVie

East Brunswick, NJ · +15 more sites

RecruitingPhase 1NCT06270706

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Sponsor: Pliant Therapeutics, Inc.

East Brunswick, NJ · +15 more sites

RecruitingPhase 1NCT05176483

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Sponsor: Exelixis

East Brunswick, NJ · Hackensack, NJ · +44 more sites

RecruitingPhase 1 / Phase 2NCT06362252

A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

Sponsor: Daiichi Sankyo

East Brunswick, NJ · Hackensack, NJ · +24 more sites

RecruitingPhase 1NCT07705035

DBC-664 in Adult Patients With Solid Tumors

Sponsor: Duboce Biopharmaceuticals, Inc.

East Brunswick, NJ · +5 more sites

RecruitingPhase 1NCT06095089

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

Sponsor: Janssen Research & Development, LLC

East Brunswick, NJ · +11 more sites

RecruitingPhase 1NCT07277413

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Sponsor: IDEAYA Biosciences

East Brunswick, NJ · +22 more sites

RecruitingPhase 3NCT07225946

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Sponsor: Janssen Research & Development, LLC

East Brunswick, NJ · New Brunswick, NJ · +57 more sites

RecruitingPhase 2NCT05489211

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Sponsor: AstraZeneca

East Brunswick, NJ · +17 more sites

RecruitingPhase 1NCT07080242

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

Sponsor: SystImmune Inc.

East Brunswick, NJ · Hackensack, NJ · New Brunswick, NJ · +21 more sites

RecruitingPhase not listedNCT05059444

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Sponsor: Guardant Health, Inc.

East Brunswick, NJ · +32 more sites

RecruitingPhase 1NCT07085104

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Sponsor: Allogene Therapeutics

East Brunswick, NJ · +15 more sites

RecruitingPhase 3NCT06203210

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Sponsor: Daiichi Sankyo

East Brunswick, NJ · Neptune City, NJ · +28 more sites

RecruitingPhase 1NCT07540572

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

Sponsor: IDEAYA Biosciences

East Brunswick, NJ · +10 more sites

RecruitingPhase 1 / Phase 2NCT07145255

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

Sponsor: MBrace Therapeutics

East Brunswick, NJ · +6 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.